| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonectomy | 5 | 2018 | 129 | 1.580 |
Why?
|
| Coronary Artery Bypass | 14 | 2022 | 487 | 1.570 |
Why?
|
| Heart Valve Prosthesis Implantation | 12 | 2022 | 428 | 1.490 |
Why?
|
| Lung Neoplasms | 9 | 2024 | 1590 | 1.410 |
Why?
|
| Hospitals, Veterans | 8 | 2021 | 354 | 1.230 |
Why?
|
| Veterans | 13 | 2022 | 1731 | 1.170 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2017 | 54 | 0.970 |
Why?
|
| Bronchoscopy | 5 | 2017 | 153 | 0.840 |
Why?
|
| Postoperative Complications | 14 | 2022 | 3015 | 0.820 |
Why?
|
| Aortic Valve Stenosis | 8 | 2022 | 330 | 0.820 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 332 | 0.760 |
Why?
|
| Coronary Artery Disease | 6 | 2021 | 747 | 0.760 |
Why?
|
| Radiosurgery | 2 | 2024 | 106 | 0.740 |
Why?
|
| Aorta, Thoracic | 9 | 2024 | 520 | 0.710 |
Why?
|
| Blood Vessel Prosthesis Implantation | 10 | 2019 | 796 | 0.660 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 4 | 2022 | 24 | 0.640 |
Why?
|
| Length of Stay | 6 | 2018 | 1289 | 0.630 |
Why?
|
| Middle Aged | 51 | 2024 | 25989 | 0.620 |
Why?
|
| Splenic Diseases | 1 | 2018 | 28 | 0.620 |
Why?
|
| Nutrition Assessment | 1 | 2019 | 133 | 0.620 |
Why?
|
| Staphylococcus epidermidis | 1 | 2018 | 41 | 0.620 |
Why?
|
| Cardiac Surgical Procedures | 6 | 2022 | 1099 | 0.590 |
Why?
|
| Endocarditis, Bacterial | 1 | 2018 | 129 | 0.570 |
Why?
|
| Abscess | 1 | 2018 | 138 | 0.570 |
Why?
|
| Aged | 41 | 2024 | 19086 | 0.560 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2018 | 138 | 0.560 |
Why?
|
| Drainage | 1 | 2018 | 257 | 0.550 |
Why?
|
| Endocarditis | 3 | 2014 | 101 | 0.530 |
Why?
|
| Bronchi | 1 | 2017 | 98 | 0.530 |
Why?
|
| Pneumothorax | 1 | 2017 | 80 | 0.520 |
Why?
|
| Treatment Outcome | 33 | 2024 | 12118 | 0.510 |
Why?
|
| Prostheses and Implants | 1 | 2017 | 150 | 0.510 |
Why?
|
| Neoplasm Staging | 7 | 2020 | 1213 | 0.500 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 4 | 2016 | 41 | 0.490 |
Why?
|
| Nursing Stations | 1 | 2014 | 1 | 0.470 |
Why?
|
| Retrospective Studies | 34 | 2024 | 16036 | 0.460 |
Why?
|
| Male | 56 | 2024 | 60086 | 0.460 |
Why?
|
| Thoracic Surgery | 4 | 2021 | 157 | 0.450 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2021 | 195 | 0.440 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2022 | 156 | 0.440 |
Why?
|
| Aortic Valve | 8 | 2022 | 433 | 0.440 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2013 | 25 | 0.440 |
Why?
|
| Humans | 78 | 2024 | 123072 | 0.440 |
Why?
|
| Mitral Valve Stenosis | 1 | 2013 | 34 | 0.430 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2013 | 63 | 0.410 |
Why?
|
| Quality Improvement | 4 | 2020 | 625 | 0.410 |
Why?
|
| Mitral Valve | 4 | 2022 | 246 | 0.400 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2013 | 78 | 0.400 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 174 | 0.400 |
Why?
|
| Female | 49 | 2024 | 65534 | 0.390 |
Why?
|
| Aortic Diseases | 4 | 2024 | 197 | 0.380 |
Why?
|
| Heart Arrest, Induced | 4 | 2021 | 73 | 0.380 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 1118 | 0.370 |
Why?
|
| United States | 20 | 2024 | 10645 | 0.370 |
Why?
|
| Intensive Care Units | 2 | 2014 | 483 | 0.370 |
Why?
|
| Hypothermia, Induced | 3 | 2016 | 161 | 0.360 |
Why?
|
| Lymph Nodes | 4 | 2017 | 376 | 0.360 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 364 | 0.360 |
Why?
|
| Aorta | 3 | 2022 | 542 | 0.360 |
Why?
|
| Time Factors | 17 | 2024 | 6222 | 0.350 |
Why?
|
| Risk Factors | 23 | 2024 | 10012 | 0.340 |
Why?
|
| Forecasting | 1 | 2011 | 354 | 0.340 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2019 | 533 | 0.330 |
Why?
|
| Risk Assessment | 13 | 2024 | 3316 | 0.320 |
Why?
|
| Vascular Surgical Procedures | 3 | 2024 | 565 | 0.320 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 5047 | 0.310 |
Why?
|
| Mitral Valve Annuloplasty | 2 | 2019 | 15 | 0.300 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 434 | 0.300 |
Why?
|
| Nicardipine | 1 | 2008 | 18 | 0.300 |
Why?
|
| Veterans Health | 3 | 2020 | 173 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2391 | 0.280 |
Why?
|
| Aortic Aneurysm, Thoracic | 5 | 2017 | 664 | 0.280 |
Why?
|
| Patient Care Team | 3 | 2019 | 548 | 0.280 |
Why?
|
| Brachiocephalic Trunk | 2 | 2017 | 35 | 0.270 |
Why?
|
| Positron-Emission Tomography | 2 | 2020 | 289 | 0.260 |
Why?
|
| Emphysema | 2 | 2019 | 66 | 0.260 |
Why?
|
| United States Department of Veterans Affairs | 7 | 2024 | 654 | 0.250 |
Why?
|
| Clinical Trials as Topic | 3 | 2022 | 1084 | 0.250 |
Why?
|
| Surgeons | 2 | 2021 | 248 | 0.240 |
Why?
|
| Image-Guided Biopsy | 2 | 2015 | 35 | 0.240 |
Why?
|
| Renal Dialysis | 3 | 2022 | 842 | 0.240 |
Why?
|
| Ventricular Function, Left | 1 | 2008 | 494 | 0.240 |
Why?
|
| Endovascular Procedures | 4 | 2013 | 729 | 0.240 |
Why?
|
| Catheterization, Peripheral | 2 | 2017 | 126 | 0.240 |
Why?
|
| Bioprosthesis | 2 | 2017 | 111 | 0.230 |
Why?
|
| Debridement | 3 | 2014 | 85 | 0.230 |
Why?
|
| Cardiac Catheterization | 4 | 2022 | 631 | 0.220 |
Why?
|
| Obesity, Morbid | 2 | 2019 | 184 | 0.220 |
Why?
|
| Septal Occluder Device | 2 | 2014 | 42 | 0.210 |
Why?
|
| Heart Valve Prosthesis | 4 | 2014 | 293 | 0.210 |
Why?
|
| Telerehabilitation | 1 | 2022 | 4 | 0.210 |
Why?
|
| Poverty | 2 | 2024 | 418 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 2055 | 0.210 |
Why?
|
| Quality Assurance, Health Care | 1 | 2024 | 207 | 0.200 |
Why?
|
| Lung | 4 | 2019 | 1461 | 0.200 |
Why?
|
| Cardiac Rehabilitation | 1 | 2022 | 24 | 0.200 |
Why?
|
| Internship and Residency | 3 | 2022 | 1159 | 0.200 |
Why?
|
| Intraoperative Complications | 2 | 2014 | 175 | 0.200 |
Why?
|
| Survival Rate | 7 | 2019 | 1997 | 0.190 |
Why?
|
| Survival Analysis | 4 | 2020 | 1472 | 0.190 |
Why?
|
| Elective Surgical Procedures | 3 | 2017 | 158 | 0.190 |
Why?
|
| Hospitals, Low-Volume | 2 | 2019 | 30 | 0.190 |
Why?
|
| Benchmarking | 1 | 2022 | 132 | 0.190 |
Why?
|
| Mediastinum | 2 | 2022 | 41 | 0.190 |
Why?
|
| Specialties, Surgical | 1 | 2022 | 79 | 0.190 |
Why?
|
| Shock | 1 | 2022 | 90 | 0.180 |
Why?
|
| Cardioplegic Solutions | 1 | 2021 | 17 | 0.180 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2019 | 713 | 0.180 |
Why?
|
| Patient Readmission | 1 | 2024 | 368 | 0.180 |
Why?
|
| Pleural Neoplasms | 1 | 2020 | 48 | 0.180 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 12 | 0.170 |
Why?
|
| Feasibility Studies | 2 | 2013 | 752 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2022 | 1004 | 0.170 |
Why?
|
| Spinal Cord Ischemia | 1 | 2019 | 26 | 0.170 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 54 | 0.170 |
Why?
|
| Complement C1q | 1 | 2019 | 19 | 0.160 |
Why?
|
| Thymectomy | 1 | 2019 | 19 | 0.160 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 86 | 0.160 |
Why?
|
| Thymoma | 1 | 2019 | 11 | 0.160 |
Why?
|
| Mediastinitis | 1 | 2019 | 14 | 0.160 |
Why?
|
| Hospital Mortality | 7 | 2020 | 1009 | 0.160 |
Why?
|
| Triage | 1 | 2020 | 140 | 0.160 |
Why?
|
| Bone Plates | 1 | 2019 | 24 | 0.160 |
Why?
|
| Thymus Neoplasms | 1 | 2019 | 29 | 0.160 |
Why?
|
| Margins of Excision | 1 | 2019 | 51 | 0.160 |
Why?
|
| Comorbidity | 4 | 2020 | 1495 | 0.160 |
Why?
|
| Sternum | 1 | 2019 | 53 | 0.160 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 117 | 0.160 |
Why?
|
| Conservative Treatment | 1 | 2018 | 32 | 0.160 |
Why?
|
| Multimorbidity | 1 | 2018 | 20 | 0.160 |
Why?
|
| Air | 1 | 2018 | 26 | 0.160 |
Why?
|
| Perfusion | 2 | 2016 | 198 | 0.160 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2019 | 51 | 0.160 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 55 | 0.150 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 1412 | 0.150 |
Why?
|
| Th17 Cells | 1 | 2019 | 90 | 0.150 |
Why?
|
| Stroke | 4 | 2019 | 956 | 0.150 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 416 | 0.150 |
Why?
|
| Endosonography | 2 | 2015 | 82 | 0.150 |
Why?
|
| Axillary Artery | 1 | 2017 | 27 | 0.150 |
Why?
|
| Adult | 15 | 2021 | 29012 | 0.150 |
Why?
|
| Robotics | 1 | 2019 | 106 | 0.140 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 6369 | 0.140 |
Why?
|
| Pulmonologists | 1 | 2017 | 4 | 0.140 |
Why?
|
| Patient Selection | 3 | 2017 | 684 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 359 | 0.140 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 100 | 0.140 |
Why?
|
| Esophagectomy | 1 | 2017 | 60 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 2 | 2016 | 434 | 0.140 |
Why?
|
| Texas | 6 | 2016 | 3562 | 0.130 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 353 | 0.130 |
Why?
|
| Activities of Daily Living | 2 | 2022 | 404 | 0.130 |
Why?
|
| Socioeconomic Factors | 3 | 2024 | 863 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2020 | 482 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 321 | 0.120 |
Why?
|
| Esophageal Neoplasms | 2 | 2017 | 359 | 0.120 |
Why?
|
| Laparoscopy | 1 | 2020 | 501 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1140 | 0.120 |
Why?
|
| Reoperation | 5 | 2016 | 819 | 0.120 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2015 | 54 | 0.120 |
Why?
|
| Receptors, Complement | 1 | 2014 | 31 | 0.120 |
Why?
|
| Conscious Sedation | 1 | 2015 | 63 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.120 |
Why?
|
| Acute Disease | 3 | 2014 | 1093 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2022 | 6027 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1000 | 0.120 |
Why?
|
| Anesthesia, General | 1 | 2015 | 111 | 0.110 |
Why?
|
| Heart Injuries | 1 | 2014 | 46 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2014 | 30 | 0.110 |
Why?
|
| Internet | 1 | 2017 | 377 | 0.110 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2014 | 133 | 0.110 |
Why?
|
| Insufflation | 1 | 2013 | 20 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1256 | 0.110 |
Why?
|
| Bronchial Fistula | 1 | 2013 | 22 | 0.110 |
Why?
|
| Pleural Diseases | 1 | 2013 | 29 | 0.110 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 216 | 0.100 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 157 | 0.100 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 56 | 0.100 |
Why?
|
| Income | 2 | 2024 | 133 | 0.100 |
Why?
|
| Registries | 2 | 2021 | 1394 | 0.100 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 181 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 2846 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 651 | 0.100 |
Why?
|
| Prosthesis-Related Infections | 1 | 2014 | 176 | 0.100 |
Why?
|
| Tracheal Neoplasms | 1 | 2012 | 21 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2012 | 120 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 2012 | 46 | 0.100 |
Why?
|
| Airway Obstruction | 1 | 2013 | 164 | 0.090 |
Why?
|
| Program Development | 1 | 2012 | 189 | 0.090 |
Why?
|
| Stents | 2 | 2017 | 872 | 0.090 |
Why?
|
| Health Resources | 1 | 2012 | 115 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1071 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 864 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2017 | 4703 | 0.090 |
Why?
|
| Prognosis | 1 | 2019 | 4513 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2012 | 268 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 993 | 0.090 |
Why?
|
| Algorithms | 2 | 2014 | 1592 | 0.080 |
Why?
|
| Hemodynamics | 3 | 2022 | 845 | 0.080 |
Why?
|
| Hospitals | 1 | 2012 | 392 | 0.080 |
Why?
|
| Disease Management | 1 | 2013 | 513 | 0.080 |
Why?
|
| Oxygen | 1 | 2013 | 547 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 626 | 0.080 |
Why?
|
| Heart Failure | 1 | 2022 | 2127 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2011 | 356 | 0.080 |
Why?
|
| Smoking | 1 | 2014 | 1031 | 0.080 |
Why?
|
| Sternotomy | 2 | 2019 | 42 | 0.080 |
Why?
|
| Antibodies | 1 | 2010 | 370 | 0.080 |
Why?
|
| Injections, Intra-Arterial | 1 | 2008 | 16 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2012 | 637 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 1862 | 0.080 |
Why?
|
| Heparin | 1 | 2010 | 227 | 0.080 |
Why?
|
| Hypotension | 1 | 2010 | 177 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2109 | 0.070 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 443 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2021 | 330 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 508 | 0.070 |
Why?
|
| Logistic Models | 3 | 2017 | 1797 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2013 | 823 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2016 | 1171 | 0.070 |
Why?
|
| Prosthesis Design | 2 | 2019 | 672 | 0.060 |
Why?
|
| Lymphatic Metastasis | 2 | 2017 | 400 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2010 | 581 | 0.060 |
Why?
|
| Propensity Score | 2 | 2017 | 211 | 0.060 |
Why?
|
| Mortality | 2 | 2017 | 228 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2015 | 115 | 0.060 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2024 | 61 | 0.060 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2016 | 238 | 0.060 |
Why?
|
| Radiotherapy Dosage | 1 | 2024 | 185 | 0.060 |
Why?
|
| Prevalence | 1 | 2010 | 2404 | 0.060 |
Why?
|
| Education, Medical, Continuing | 2 | 2017 | 138 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 586 | 0.050 |
Why?
|
| Educational Status | 1 | 2024 | 270 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2022 | 50 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2014 | 343 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2019 | 1389 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2022 | 75 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2022 | 175 | 0.050 |
Why?
|
| Vasoconstrictor Agents | 1 | 2022 | 137 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2022 | 161 | 0.050 |
Why?
|
| Accreditation | 1 | 2021 | 81 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 2825 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 133 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 1305 | 0.050 |
Why?
|
| Cattle | 1 | 2022 | 558 | 0.040 |
Why?
|
| Neoplasms | 1 | 2015 | 2758 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2020 | 50 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1260 | 0.040 |
Why?
|
| Early Medical Intervention | 1 | 2020 | 30 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 117 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 294 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2019 | 1549 | 0.040 |
Why?
|
| Preventive Health Services | 1 | 2020 | 56 | 0.040 |
Why?
|
| Data Collection | 1 | 2021 | 383 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2019 | 3720 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 101 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 134 | 0.040 |
Why?
|
| Smoke | 1 | 2019 | 46 | 0.040 |
Why?
|
| Incidence | 2 | 2016 | 3043 | 0.040 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 23 | 0.040 |
Why?
|
| Tobacco Products | 1 | 2019 | 61 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2019 | 233 | 0.040 |
Why?
|
| Age Factors | 2 | 2016 | 2803 | 0.040 |
Why?
|
| Patient Safety | 2 | 2013 | 394 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2019 | 145 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 186 | 0.040 |
Why?
|
| Thoracotomy | 1 | 2019 | 108 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2019 | 172 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 350 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2020 | 445 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 216 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 684 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 121 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 697 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 214 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2021 | 760 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 437 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 4285 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 2016 | 86 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 133 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 300 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 304 | 0.030 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 2014 | 19 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 73 | 0.030 |
Why?
|
| Complement C3a | 1 | 2014 | 19 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2014 | 27 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 61 | 0.030 |
Why?
|
| Complement C3 | 1 | 2014 | 47 | 0.030 |
Why?
|
| Complement Activation | 1 | 2014 | 52 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 3665 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2014 | 71 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2014 | 66 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 165 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2014 | 35 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3370 | 0.030 |
Why?
|
| Bronchial Diseases | 1 | 2013 | 12 | 0.030 |
Why?
|
| Tracheal Diseases | 1 | 2013 | 15 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 132 | 0.030 |
Why?
|
| Allografts | 1 | 2014 | 190 | 0.030 |
Why?
|
| Animals | 3 | 2022 | 33793 | 0.030 |
Why?
|
| Advisory Committees | 1 | 2014 | 148 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 3042 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1244 | 0.030 |
Why?
|
| Hospital Bed Capacity | 1 | 2012 | 24 | 0.030 |
Why?
|
| Fistula | 1 | 2013 | 50 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2013 | 122 | 0.030 |
Why?
|
| Patients | 1 | 2013 | 121 | 0.030 |
Why?
|
| Device Removal | 1 | 2014 | 222 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1099 | 0.030 |
Why?
|
| Angiography | 1 | 2013 | 215 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2013 | 193 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1680 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 450 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3240 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2307 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 234 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 92 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2012 | 78 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1909 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2012 | 190 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1237 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2013 | 197 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2014 | 378 | 0.020 |
Why?
|
| Perception | 1 | 2012 | 219 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 678 | 0.020 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2010 | 12 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2014 | 0.020 |
Why?
|
| Morbidity | 1 | 2010 | 241 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2014 | 676 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 601 | 0.020 |
Why?
|
| Histamine | 1 | 2010 | 44 | 0.020 |
Why?
|
| Platelet Count | 1 | 2010 | 133 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 464 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 228 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2010 | 350 | 0.020 |
Why?
|
| Echocardiography | 1 | 2012 | 1049 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2526 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 8837 | 0.020 |
Why?
|
| Obesity | 1 | 2016 | 2227 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 2961 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4490 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 17540 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 19102 | 0.010 |
Why?
|